Tma Viewer Logo


Please Click The Title Of The Paper To View Login Credentials*

Submitted Papers:

+Bernard P :: TRIM29
+Chung C :: Tissue microarrays are equivalent to whole sections for clinical assessment of breast cancer biomarkers: a pilot study
+Endo, M :: NY-ESO-1 expression in mesenchymal tumors
+Gilks B :: Her2 negative / 1+
+Huntsman D :: RET (02-008) image access
+Koebel M :: 08-001 Image archive
+Sun, Y :: Type Igamma PIP Kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer
+Ursini-Siegel J :: Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development
+Voduc D :: Clinical implications of alpha-Basic Crystallin

Published Papers:

+Badve S :: FOXA1 Expression in Breast CanceróCorrelation with Luminal Subtype A and Survival
+Brown L :: ESR1 gene amplification in breast cancer: a common phenomenon?
+Cheang MCU :: Immunohistochemical detection of estrogen receptor in breast cancer using the new rabbit monoclonal antibody SP1 predicts survival better than mouse monoclonal antibody 1D5
+Cheang MCU :: Basal-like breast cancer is better defined by five biomarkers than by triple negative
+Cheang, MCU :: Ki67 Index, HER2 Status, and Prognosis of Patients with Luminal B Breast Cancer
+Cheng, H :: Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.
+Chia S :: Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers
+Chia S :: A 50 Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit to Adjuvant Tamoxifen
+Chiu CG :: HER-3 Over-Expression is Prognostic of Reduced Breast Cancer Survival: A Study of 4,046 Patients.
+Crabb SJ :: Can a clinically relevant subset of breast cancer patients with four or more involved axillary nodes be identified through tissue based biomarkers: a feasibility study
+Endo, M :: Activating transcription factor 2 in mesenchymal tumors
+Han G :: Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases
+Koebel M :: Ovarian Carcinoma Subtypes are Different Diseases: Implications for Biomarker Studies
+Kojic LD :: Raft-dependent endocytosis of autocrine motility factor is phosphatidylinositol 3-kinase-dependent in breast carcinoma cells.
+Kulkarni G :: Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer.
+Liu S :: CD8+ Lymphocyte Infiltration Is an Independent Favorable Indicator of Survival in Basal-like Breast Cancer
+Liu S :: Prognostic significance of FOXP3+ lymphocyte infiltration depends on ER and HER2 expression, and cytotoxic T-cell Infiltration status in breast cancer
+Moyano JV :: Alpha-B Crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer
+NA :: normal-like HE
+Ng TL :: Nuclear beta-catenin in mesenchymal tumors
+Nielsen T :: CALGB Presentation Dec 2007
+Prat A :: Prognostic Significance of Progesterone Receptor-Positive Tumor Cells within Immunohistochemically-defined Luminal A Breast Cancer
+Rajput AB :: Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4620 cases
+Steigen SE :: Clinicopathologic factors and nuclear morphometry as independent prognosticators in KIT positive gastrointestinal stromal tumor
+Steigen SE :: Expression of Insulin-like growth factor 2 in mesenchymal neoplasms
+Terry J :: TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies
+Turashvili G :: Interobserver reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis
+Turashvili G :: P-cadherin expression in a population based series of 3,992 breast cancers shows strong association with high grade subtypes
+Turbin DA :: MDM2 protein expression is a negative prognostic marker in breast carcinoma.
+Turbin DA :: Automated Quantitative Analysis of Estrogen Receptor
+Voduc D :: GATA-3 Expression in Breast Cancer has a Strong Association with Estrogen Receptorbut Lacks Independent Prognostic Value
+Voduc D :: The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype
+Voduc D :: Breast cancer subtypes and the risk of local and regional relapse
+Won J :: A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard
+Yerushalmi R :: Insulin like growth factor (IGF-1R) in breast cancer subtypes
*Mac user please use Firefox web browser
StatsCopyright © 2014 Genetic Pathology Evaluation Centre. All rights reserved.